Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [519]

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first...

Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients ( Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands )

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail...

Dr Guido Gini - Università Politecnica delle Marche, Ancona, Italy

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail patients with diffuse large B-cell lymphoma. ( Dr Guido Gini - Università Politecnica delle Marche, Ancona, Italy )

Palliative care and strategies for screening and early detection in Africa

Dr Miriam Mutebi - Aga Khan University, Nairobi, Kenya

Palliative care and strategies for screening and early detection in Africa ( Dr Miriam Mutebi - Aga Khan University, Nairobi, Kenya )

Latest in Philadelphia chromosome-positive ALL (Ph+ ALL)

Prof Robin Foà - Sapienza University of Rome, Rome, Italy

Latest in Philadelphia chromosome-positive ALL (Ph+ ALL) ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )

Quality of life and safety in novel therapies for prostate cancer

Prof Heather Payne, Prof Alicia Morgans and Prof Bertrand Tombal

Quality of life and safety in novel therapies for prostate cancer ( Prof Heather Payne, Prof Alicia Morgans and Prof Bertrand Tombal )

Exceptional response to oral metronomic chemotherapy in a rare case of...

Dr Akhil Kapoor - Tata Memorial Hospital, Mumbai, India

Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal mucosal melanoma ( Dr Akhil Kapoor - Tata Memorial Hospital, Mumbai, India )

OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Integration of palliative care in oncology

Dr Tonje Lundeby - University of Oslo, Oslo, Norway

Integration of palliative care in oncology ( Dr Tonje Lundeby - University of Oslo, Oslo, Norway )

Integration of palliative care in oncology

Prof Stein Kaasa - University of Oslo, Oslo, Norway

Integration of palliative care in oncology ( Prof Stein Kaasa - University of Oslo, Oslo, Norway )

GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL

Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The...

GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL ( Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The Netherlands )

Real world evidence on the use of antibody drug conjugates in peripheral T-cell...

Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut...

Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma ( Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Lebanon )

Palliative Care: Industry and Academia – Tensions and Opportunities

Dr Jim Cleary - IU Simon Cancer Center, Indianapolis, USA

Palliative Care: Industry and Academia – Tensions and Opportunities ( Dr Jim Cleary - IU Simon Cancer Center, Indianapolis, USA )

More from ecancer